FDA Preparing To Clear 10M Johnson & Johnson COVID Vaccine Doses From Baltimore's Emergent BioSolutions
FDA Preparing To Clear 10M Johnson & Johnson COVID Vaccine Doses From Baltimore's Emergent BioSolutions

U.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory,  WJZ has confirmed.

But material to make many more must be thrown out because of possible contamination, according to the Associated Press.